Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burrill Media was a specialized media and market intelligence firm focused exclusively on the life sciences and biotechnology sectors. As a subsidiary of the venture capital firm Burrill & Company, it provided industry-leading analysis through its flagship publication, "The Burrill Report," and its comprehensive annual biotech industry books. The company's offerings included data-driven insights into financing trends, M&A activity, and regulatory developments for a global audience of healthcare executives and investors. It also hosted various industry conferences and webinars that facilitated networking and knowledge sharing within the life sciences community. Burrill Media ceased operations following the legal dissolution and regulatory actions against its parent company and founder, G. Steven Burrill, in the mid-2010s. At its peak, it was considered one of the most influential sources of strategic information for the biotechnology industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Burrill Media.